New aprepitant suspension for use in children

Emend (aprepitant) is now available as a powder for oral suspension, allowing use of the neurokinin NK1 antagonist in children aged 6 months and over.

Licensed for the prevention of nausea and vomiting associated with highly and moderately emetogenic chemotherapy, the oral suspension can be prescribed for children aged 6 months to 11 years weighing at least 6kg. The recommended dose is based on body weight and should be administered one hour before chemotherapy on days 1, 2 and 3 or in the morning on days 2 and 3 if no chemotherapy is being given.

The oral suspension is supplied as 125mg powder in a sachet to provide a 125mg/5ml oral suspension after reconstitution. Emend capsules containing 80mg or 125mg aprepitant remain available for adults and adolescents.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more